Novartis India Limited
NSE:NOVARTIND.NS
672.25 (INR) • At close November 21, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Novartis India Limited |
Symbool | NOVARTIND.NS |
Munteenheid | INR |
Prijs | 674 |
Beurswaarde | 16,641,599,200 |
Dividendpercentage | 5.56% |
52-weken bereik | 537 - 909 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sanjay Prabhakar Murdeshwar |
Website | https://www.novartis.in |
An error occurred while fetching data.
Over Novartis India Limited
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)